openPR Logo
Press release

Global Treatment Syndromes Dementia Movement Disorders Market Market to Witness Rapid Growth in Demand During 2020

10-05-2023 11:33 AM CET | Health & Medicine

Press release from: Persistence Market Research

Global Treatment Syndromes Dementia Movement Disorders Market

According to a new market report published by Persistence Market Research "Global Market Study on Treatment for Syndromes of Dementia and Movement Disorders: Asia to Witness Highest Growth by 2020," the global treatment for syndromes of dementia and movement disorders market was valued at USD 12,859.8 million in 2014 and is expected to grow at a CAGR of 8.6% from 2014 to 2020, to reach an estimated value of USD 21,154.8 million in 2020.

The treatment for syndromes of dementia and movement disorders market is witnessing significant growth due to increasing R&D investments in drug discovery and developments. In addition, increasing prevalence of neurodegenerative disorders and rising awareness about mental disorders are also driving the growth of the market. However, most of the drugs fail in Phase III due to lack of sufficient knowledge about the mechanisms of the brain and the unknown causes of the disease.

๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐…๐จ๐ซ ๐…๐ซ๐ž๐ž ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐จ๐Ÿ ๐“๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ ๐’๐ฒ๐ง๐๐ซ๐จ๐ฆ๐ž๐ฌ ๐ƒ๐ž๐ฆ๐ž๐ง๐ญ๐ข๐š ๐Œ๐จ๐ฏ๐ž๐ฆ๐ž๐ง๐ญ ๐ƒ๐ข๐ฌ๐จ๐ซ๐๐ž๐ซ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ @ https://www.persistencemarketresearch.com/samples/2833

In addition, lack of comprehensive therapeutic management, strict regulations, and time-consuming drug approval process inhibit the growth of the market. The global treatment for syndromes of dementia and movement disorders market is anticipated to grow from an estimated USD 12,859.8 million in 2014 to USD 21,154.8 million in 2020 at a CAGR of 8.6% during the forecast period.

In North America, growing aging population and rising incidence of neurodegenerative disease are driving the use of treatment for syndromes of dementia and movement disorders in the market. In addition, lack of proper medication is also fuelling the growth of treatments for syndromes of dementia and movement disorders market.

In Europe, the treatment for syndromes of dementia and movement disorders market is driven by rising incidence of mental disorder related disease and growing aging population. On the other hand, various awareness programs were launched by public and private health institutions to control dementia and movement disorders, which would increase the use of dementia and movement disorder drugs in the region.

However, in Asia the growth for treatment for syndromes of dementia and movement disorders is much higher than developed countries due to widening health insurance penetration, and large population base.

Hoffmann-La Roche, Ltd., Novartis AG, Merck & Co., Inc., Sanofi S.A., Valeant Pharmaceutical International, Inc., AstraZeneca GmbH and Pfizer, Inc. are some of the major players of treatment for syndromes of dementia and movement disorders market.

๐…๐จ๐ซ ๐œ๐ซ๐ข๐ญ๐ข๐œ๐š๐ฅ ๐ข๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐จ๐ง ๐ญ๐ก๐ข๐ฌ ๐ฆ๐š๐ซ๐ค๐ž๐ญ, ๐ซ๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐Ÿ๐จ๐ซ ๐œ๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐š๐ญ๐ข๐จ๐ง ๐ก๐ž๐ซ๐ž @ https://www.persistencemarketresearch.com/request-customization/2833

Some of the latest trends that have been observed in the global cell and tissue culture supplies market include increasing number of contract research and growing popularity of serum-free, specialty, and customized media solutions.

Thermo Fisher Scientific, Inc. is a leading player in the global market for cell and tissue culture supplies market. Some of the other major players in cell and tissue culture supplies market are BD Diagnostics, EMD Millipore, Corning, Inc. and Lonza Group.

๐“๐ก๐ž ๐ญ๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ ๐Ÿ๐จ๐ซ ๐ฌ๐ฒ๐ง๐๐ซ๐จ๐ฆ๐ž๐ฌ ๐จ๐Ÿ ๐๐ž๐ฆ๐ž๐ง๐ญ๐ข๐š ๐š๐ง๐ ๐ฆ๐จ๐ฏ๐ž๐ฆ๐ž๐ง๐ญ ๐๐ข๐ฌ๐จ๐ซ๐๐ž๐ซ๐ฌ ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ข๐ฌ ๐ฌ๐ž๐ ๐ฆ๐ž๐ง๐ญ๐ž๐ ๐š๐ฌ ๐Ÿ๐จ๐ฅ๐ฅ๐จ๐ฐ๐ฌ:

๐“๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ ๐Ÿ๐จ๐ซ ๐ฌ๐ฒ๐ง๐๐ซ๐จ๐ฆ๐ž๐ฌ ๐จ๐Ÿ ๐๐ž๐ฆ๐ž๐ง๐ญ๐ข๐š ๐š๐ง๐ ๐ฆ๐จ๐ฏ๐ž๐ฆ๐ž๐ง๐ญ ๐๐ข๐ฌ๐จ๐ซ๐๐ž๐ซ๐ฌ ๐ฆ๐š๐ซ๐ค๐ž๐ญ, ๐›๐ฒ ๐๐ซ๐ฎ๐ ๐ฌ ๐ฎ๐ฌ๐ž๐ ๐ญ๐จ ๐ญ๐ซ๐ž๐š๐ญ ๐ฉ๐ซ๐จ๐ ๐ซ๐ž๐ฌ๐ฌ๐ข๐ฏ๐ž ๐๐ž๐ฆ๐ž๐ง๐ญ๐ข๐š

Diseases based therapeutics under progressive dementia
Drugs for progressive dementia

๐“๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ ๐Ÿ๐จ๐ซ ๐ฌ๐ฒ๐ง๐๐ซ๐จ๐ฆ๐ž๐ฌ ๐จ๐Ÿ ๐๐ž๐ฆ๐ž๐ง๐ญ๐ข๐š ๐š๐ง๐ ๐ฆ๐จ๐ฏ๐ž๐ฆ๐ž๐ง๐ญ ๐๐ข๐ฌ๐จ๐ซ๐๐ž๐ซ๐ฌ ๐ฆ๐š๐ซ๐ค๐ž๐ญ, ๐›๐ฒ ๐๐ซ๐ฎ๐ ๐ฌ ๐ฎ๐ฌ๐ž๐ ๐ญ๐จ ๐ญ๐ซ๐ž๐š๐ญ ๐ฉ๐ซ๐จ๐ ๐ซ๐ž๐ฌ๐ฌ๐ข๐ฏ๐ž ๐๐ž๐ฆ๐ž๐ง๐ญ๐ข๐š ๐ฐ๐ข๐ญ๐ก ๐จ๐ญ๐ก๐ž๐ซ ๐ง๐ž๐ฎ๐ซ๐จ๐ฅ๐จ๐ ๐ข๐œ๐š๐ฅ ๐š๐›๐ง๐จ๐ซ๐ฆ๐š๐ฅ๐ข๐ญ๐ข๐ž๐ฌ

Disease based therapeutics under progressive dementia with other neurological abnormalities
Drugs for progressive dementia with other neurological abnormalities

๐“๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ ๐Ÿ๐จ๐ซ ๐ฌ๐ฒ๐ง๐๐ซ๐จ๐ฆ๐ž๐ฌ ๐จ๐Ÿ ๐๐ž๐ฆ๐ž๐ง๐ญ๐ข๐š ๐š๐ง๐ ๐ฆ๐จ๐ฏ๐ž๐ฆ๐ž๐ง๐ญ ๐๐ข๐ฌ๐จ๐ซ๐๐ž๐ซ๐ฌ ๐ฆ๐š๐ซ๐ค๐ž๐ญ, ๐›๐ฒ ๐๐ซ๐ฎ๐ ๐ฌ ๐ฎ๐ฌ๐ž๐ ๐ญ๐จ ๐ญ๐ซ๐ž๐š๐ญ ๐ฆ๐จ๐ฏ๐ž๐ฆ๐ž๐ง๐ญ ๐๐ข๐ฌ๐จ๐ซ๐๐ž๐ซ๐ฌ

Diseases based therapeutics under movement disorders
Drugs for movement disorders

๐“๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ ๐Ÿ๐จ๐ซ ๐ฌ๐ฒ๐ง๐๐ซ๐จ๐ฆ๐ž๐ฌ ๐จ๐Ÿ ๐๐ž๐ฆ๐ž๐ง๐ญ๐ข๐š ๐š๐ง๐ ๐ฆ๐จ๐ฏ๐ž๐ฆ๐ž๐ง๐ญ ๐๐ข๐ฌ๐จ๐ซ๐๐ž๐ซ๐ฌ ๐ฆ๐š๐ซ๐ค๐ž๐ญ, ๐›๐ฒ ๐ ๐ž๐จ๐ ๐ซ๐š๐ฉ๐ก๐ฒ

North America
Europe
Asia
Rest of the World (RoW)

๐๐ฎ๐ฒ ๐“๐ก๐ž ๐‚๐จ๐ฆ๐ฉ๐ฅ๐ž๐ญ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐ญ๐จ ๐ซ๐ž๐š๐ ๐ญ๐ก๐ž ๐š๐ง๐š๐ฅ๐ฒ๐ฌ๐ž๐ ๐ฌ๐ญ๐ซ๐š๐ญ๐ž๐ ๐ข๐ž๐ฌ ๐š๐๐จ๐ฉ๐ญ๐ž๐ ๐›๐ฒ ๐ญ๐ก๐ž ๐ญ๐จ๐ฉ ๐ฏ๐ž๐ง๐๐จ๐ซ๐ฌ ๐ž๐ข๐ญ๐ก๐ž๐ซ ๐ญ๐จ ๐ซ๐ž๐ญ๐š๐ข๐ง ๐จ๐ซ ๐ ๐š๐ข๐ง ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ฌ๐ก๐š๐ซ๐ž@ https://www.persistencemarketresearch.com/checkout/2833

๐€๐›๐จ๐ฎ๐ญ ๐ฎ๐ฌ:

Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductors and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐ฎ๐ฌ:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales -sales@persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Treatment Syndromes Dementia Movement Disorders Market Market to Witness Rapid Growth in Demand During 2020 here

News-ID: 3236172 • Views: โ€ฆ

More Releases from Persistence Market Research

Bioplastics Packaging Market Size to Reach US$ 23,818.9 Mn by 2033 at 12.5% CAGR
Bioplastics Packaging Market Size to Reach US$ 23,818.9 Mn by 2033 at 12.5% CAGR
โžค Market Overview The global bioplastics packaging market is witnessing robust growth, driven by rising environmental awareness, government regulations, and a strong consumer shift toward sustainable packaging solutions. Bioplastics packaging is derived from renewable resources such as corn starch, sugarcane, cellulose, and vegetable fats, making it an attractive alternative to traditional petroleum based plastics. With increasing concerns over plastic pollution and carbon emissions, industries such as food and beverages, consumer goods,โ€ฆ
Carbon Footprint Management Market to Reach US$17.0 Bn by 2031, Growing at a CAGR of 7.2 Percent
Carbon Footprint Management Market to Reach US$17.0 Bn by 2031, Growing at a CAG โ€ฆ
โžค Market Overview The carbon footprint management market is rapidly emerging as a crucial segment within the sustainability and environmental technology landscape. Organizations across industries are under increasing pressure to adopt solutions that measure, monitor, and mitigate greenhouse gas emissions. With governments imposing stricter carbon regulations, businesses aiming to achieve net zero commitments, and consumers becoming more conscious about sustainability, carbon footprint management solutions are becoming an essential business priority. Theseโ€ฆ
Zero Liquid Discharge Market to Reach US$ 12.9 Bn by 2032 with 8.1% CAGR Growth - Persistence Market Research
Zero Liquid Discharge Market to Reach US$ 12.9 Bn by 2032 with 8.1% CAGR Growth โ€ฆ
โžค Overview of the Market The zero liquid discharge (ZLD) market is expanding rapidly as industries worldwide adopt advanced water treatment systems to minimize environmental impact and comply with stringent regulations. ZLD technology eliminates liquid waste discharge by recovering and reusing water, leaving only solid residues. This system is gaining momentum in highly water-intensive sectors such as power generation, oil and gas, textiles, pharmaceuticals, and chemicals, where water scarcity and regulatoryโ€ฆ
Abrasives Market to Reach US$ 77.22 Bn by 2032 with Steady Growth at 5.75% CAGR - Persistence Market Research
Abrasives Market to Reach US$ 77.22 Bn by 2032 with Steady Growth at 5.75% CAGR โ€ฆ
โžค Overview of the Market The global abrasives market has been witnessing robust expansion as industries increasingly rely on abrasive materials for grinding, cutting, polishing, and finishing applications. These materials, which include both natural and synthetic varieties, are critical to sectors such as automotive, construction, aerospace, and metal fabrication. As manufacturing activities continue to scale globally, the demand for precision tools and surfaces is fueling the adoption of abrasives. According toโ€ฆ

All 5 Releases


More Releases for Treatment

Trigeminal Neuralgia Treatment Market Size, Trigeminal Neuralgia Treatment Marke โ€ฆ
Trigeminal Neuralgia Treatment Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Trigeminal Neuralgia Treatment research data, benefit, gross margin, worldwide marketโ€ฆ
Medical Tourism Market Report by Treatment Type (Dental Treatment, Cosmetic Trea โ€ฆ
The global medical tourism market accounted for $104.68 billion in 2019, and is projected to reach $273.72 billion by 2027, registering a CAGR of 12.8% from 2019 to 2027 in terms of value. View Full Report: https://reports.valuates.com/market-reports/ALLI-Auto-0P310/medical-tourism In terms of volume, the global medical tourism market accounted for 23,042.90 thousand patients in 2019, and is projected to reach 70,358.61 thousand patients by 2027, registering a CAGR of 15.0% from 2019 toโ€ฆ
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products. Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,โ€ฆ
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products. Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,โ€ฆ
Medical Tourism Market by Treatment Type (Dental Treatment, Cosmetic Treatment, โ€ฆ
Medical Tourism Market Overview: The global medical tourism market was valued at $53,768 million in 2017, and is estimated to reach at $143,461 million by 2025, registering a CAGR of 12.9% from 2018 to 2025. Organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers home country is defined as medical tourism. Medical tourists travel abroad for the maintenance, enhancement,โ€ฆ
Substance Use Disorder Treatment Market By Type (Alcohol abuse treatment, Nicoti โ€ฆ
According to World Health Organization (WHO), the leading cause of disability around the world is not a physical disease, but a serious mood disorder known as depression. Around 350 million people suffer from depression worldwide, and that only about 50% of these individuals will ever receive treatment. According to Anxiety and Depression Association of America, in the U.S., over 15 million adults experience an episode of clinical depression in anyโ€ฆ